论文部分内容阅读
目的比较低分子右旋糖苷和参麦注射液治疗血液透析(简称血透)低血压的疗效。方法对20例血透相关性低血压患者先后用低分子右旋糖苷和参麦注射液治疗2个疗程,比较两药对血透相关性低血压的疗效。结果参麦注射液的有效率为60%,低分子右旋糖苷的有效率为90%,差异有统计学意义(P<0.05)。结论低分子右旋糖苷治疗血透相关性低血压的疗效优于参麦注射液。
Objective To compare the efficacy of low molecular weight dextran and Shenmai injection in the treatment of hemodialysis (referred to as hemodialysis) hypotension. Methods 20 patients with hemodialysis-related hypotension were treated with low molecular weight dextran and shenmai injection for two courses of treatment to compare the effects of two drugs on hemodialysis-related hypotension. Results The effective rate of Shenmai injection was 60%, and the effective rate of low molecular weight dextran was 90%, the difference was statistically significant (P <0.05). Conclusion The therapeutic effect of low molecular weight dextran on hemodialysis-related hypotension is better than that of Shenmai injection.